Trial Profile
Phase I/II chemosensitization trial of burixafor in combination with fludarabine and cytarabine in adults with relapsed or refractory acute myeloid leukemia
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Burixafor (Primary) ; Cytarabine; Fludarabine
- Indications Stem cell mobilisation
- Focus Adverse reactions; Therapeutic Use
- 26 Mar 2015 New trial record
- 18 Mar 2015 According to a TaiGen Biotechnology media release, this trial is planned for 2015.